Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05623059 · ClinicalTrials.gov registry record · Phase 1
Evaluate Pharmacokinetics and Safety of Slow Release DHEA
A Phase 1 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT05623059: Completed Phase 1 study, sponsored by Indiana University.
NCT05623059 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 18 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05623059, a Phase 1 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.
Primary Outcome
The objective is to determine the maximum tolerated dose of slow release DHEA in patients with asthma and AA or AC genotype by measuring the presence in and difference of pharmacokinetics of DHEA in the blood at two dose levels (50mg and 100mg).
Interventions
- DRUG Slow Release DHEA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-03-03 |
| Est. Completion | 2025-04-24 |
| Phase | Phase 1 |
What the finished NCT05623059 record still lists
NCT05623059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Slow Release DHEA is the first listed.
NCT05623059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05623059 about?
NCT05623059 is a clinical study titled "Evaluate Pharmacokinetics and Safety of Slow Release DHEA". This is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.
What is the current status of trial NCT05623059?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2023-03-03. Estimated completion is 2025-04-24.
What interventions are being tested in trial NCT05623059?
The interventions under investigation include: Slow Release DHEA (DRUG).
Who is sponsoring clinical trial NCT05623059?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05623059's enrollment target sits among peer trials
18 1720th of 2000 higher than 216 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI